Article
Intratumoral Resident Microbes Directly Participate in Resistance to EGFR-TKI Targeted Drug Therapy through Metabolism in NSCLC
2025-03-12
Abstract excerpt
EGFR-TKIs targeted therapy represents a cornerstone in the treatment of non-small cell lung cancer (NSCLC). Nonetheless, a subset of patients inevitably develops acquired resistance to EGFR-TKIs, posing a significant clinical challenge. An increasing number of evidence has documented the presence of microbial communities within tumor microenvironments, but the potential interplay between tumor-resident microbiota...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 48e42f36-8dea-583a-9de7-6de51e80ef8c
- DOI
- 10.1101/2025.03.12.642829
